Acrivon Therapeutics Inc. Common Stock

REPLAY BUTTONS

∣‹ ‹‹ ∥ › ›› ›∣

POSITION	OPEN	PROFIT	P & L
LONG
SHORT

Acrivon Therapeutics Inc. Common Stock. Replay the stock market charts of ACRV day by day, back to 2003. Open long and short positions without spending any money.

ACRV Daily Chart

ACRV Options Chain

Is a Surprise Coming for Acrivon Therapeutics ( ACRV ) This Earnings Season?
May 10, 2024
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316 - Acrivon Therapeutics
April 17, 2024
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
April 17, 2024
Crude Oil Down Over 1%; Cognyte Software Shares Plummet - Cognyte Software ( NASDAQ:CGNT ) , Acrivon Therapeutics ( NASDAQ:ACRV )
April 9, 2024
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
April 9, 2024
Dow Dips 150 Points; Laser Photonics Shares Spike Higher - Biophytis ( NASDAQ:BPTS ) , Acrivon Therapeutics ( NASDAQ:ACRV )
April 9, 2024
Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On? - Acrivon Therapeutics ( NASDAQ:ACRV )
April 9, 2024
Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings - Acrivon Therapeutics ( NASDAQ:ACRV ) , Hub Cyber Security ( NASDAQ:HUBC )
April 9, 2024
Acrivon Therapeutics Announces $130 Million Private Placement Financing - Acrivon Therapeutics ( NASDAQ:ACRV )
April 9, 2024
Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics ( AP3 ) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316
March 5, 2024

ACRV Free Cash Flow

ACRV Income Statement

ACRV Stock Price vs Net Income

ACRV Financial Reports